IVF suits female-factor infertility with normal sperm, ICSI suits male-factor infertility or low fertilisation in previous IVF, and IMSI suits severe male-factor cases with poor sperm morphology or high DNA fragmentation. The core decision depends on semen quality and any past fertilisation history.

According to Dr. Mohit Saraogi, an experienced IVF specialist at Saraogi Hospital, couples often shop between clinics for the “highest technology” option without understanding the clinical indication, “picking IMSI when you don’t need it won’t improve your odds, and picking regular IVF when you actually need ICSI can cost you a cycle. The treatment has to match the diagnosis, not the marketing.”

All three treatments look nearly identical until the eggs reach the lab, and that’s where the decision actually matters for outcomes.

The instinct to pick the most expensive option almost never pays off in fertility treatment, and a proper infertility treatment workup lines the protocol up with the actual diagnosis rather than the price tag.

What most couples miss is that the choice between these three is a clinical one, decided off lab reports, previous cycle outcomes, and semen parameters, not whichever treatment sounds more advanced to the ear.

• Semen: Men with sperm concentration below 15 million per ml, motility under 40 percent, or strict-criteria abnormal morphology above 96 percent are rarely good candidates for standard IVF, and ICSI treatment is where most of these couples eventually land as a first-line protocol.
• Fertilisation: When a couple’s previous IVF cycle returned fertilisation rates under 30 percent despite a normal-looking semen report, the problem is rarely the lab environment itself, it’s the sperm-egg interaction, and the next cycle almost always moves to ICSI on that basis.
• DNA damage: Sperm DNA fragmentation index crossing 30 percent, two or three early miscarriages in a row, or a couple of failed ICSI cycles with textbook embryos are the clinical triggers that push a treating team toward IMSI, which filters out sperm that standard ICSI would have passed as healthy.
• Female factor: For tubal blockage, endometriosis, advanced maternal age with a healthy partner semen report, or plain unexplained infertility, standard IVF usually delivers results on par with ICSI, and spending on IMSI here just inflates the bill without adding any real clinical value.

Protocol shifts between cycles aren’t unusual at all for the same couple, and this is also why post-transfer signals such as bleeding after IVF get read so carefully alongside the semen report before the next plan is locked.

References:

• National Institutes of Health — ICSI vs conventional IVF outcomes
• World Health Organization — Infertility overview